FilingSEC EDGAR8-K
Kairos Pharma wins Biotech Breakthrough Award for ENV-105
· SEC accepted
StageClinical-stage
Filing content
Kairos Pharma announced that its cancer drug candidate ENV-105 has been named the Cancer Immunology Solution of the Year in the 2026 Biotech Breakthrough Awards.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…